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translocation in skeletal muscle can be induced by exercise or electro-stimulation [15] . Studies in diabetic patients revealed that hyperglycaemia leads to increased glucose uptake in skeletal muscle in a glucose concentration-dependent fashion [16] . The mechanism by which hyperglycaemia induces glucose uptake is poorly understood. Studies with cultured myotubes and isolated rat skeletal muscle showed that short-term hyperglycaemia is an insulin-independent inducer of GLUT4 translocation [17] and that PKC could be involved in this effect [17±24] . Moreover, studies with cultured cells [25] and animal models [17] show enhanced PKC activity is involved in mediating insulin resistance. The activation of PKC has been explained by the finding that the high glucoseinduced glucose metabolism leads to increased synthesis of DAG which in turn activates the corresponding PKC isoforms [26] . Short-term hyperglycaemia was reported to activate PKC isoforms in different cells [17, 25±28] and in isolated rat skeletal muscle [17, 18, 20] .
It has been shown that activated PKCs are involved in stimulating glucose transport [29±35] and translocation of glucose transporters by a mechanism which is distinct from that of insulin [17, 18, 20, 30, 31, 35, 36] . Other studies have focussed on the effect of PKC on the insulin signalling cascade showing that activation of PKC inhibits insulin-stimulated glucose transport in rat heart and skeletal muscle and rat adipocytes [21, 29, 37] . Taken together, in vitro studies indicate that acute increases in glucose induce activation of PKC which, on one hand, induces insulin-independent glucose uptake and, on the other hand, could mediate insulin resistance. To study if the proposed mechanisms are relevant in the intact organism, we used the glucose-infused rat model originally developed by Leahy et al. [38] . In this model, continuous systemic glucose oversupply induces insulin resistance in skeletal muscle and leads to significant hyperglycaemia [38±40] . Within days rats adapt to this state and reduce blood glucose to normal concentrations by processes which are not known [39, 40] . The long-term glucose oversupply results in an increased glucose clearance with enhanced glucose uptake, lipogenesis and insulin action in adipose tissue while skeletal muscle showed a sustained insulin resistance with triglyceride accumulation [40] . It seems that this model mimics the pathobiochemical situation in human subjects with nutrient oversupply and subsequent insulin resistance associated with increased lipid accumulation in adipose tissue and skeletal muscle. Furthermore, the glucose oversupply leads to enhanced glucose sensitivity of the beta cell, ie. the beta cells of glucose-infused rats show enhanced insulin secretion at lower glucose concentrations [41] . This data could explain the hyperinsulinaemia seen in GR after 5 days, in spite of normoglycaemia (Table 2). Because these insulin concentrations might not explain the excessively increased glucose uptake into insulin resistant skeletal muscle, we studied the molecular mechanism of glucose-uptake under these conditions.
Materials and methods
Ketamine (Ketanest, Parke-Davis, Freiburg, Germany), Rompun (Bayer, Leverkusen, Germany) silicone rubber (Silastic, Dow Corning, Midland, Mich., USA), heparin (Liquemine, Roche, Grenzach, Switzerland), swivel (ZAK-Medizintechnik, Munich, Germany), syringe pump (Perfusor B. Braun, Melsungen, Germany), 50 % glucose (Fresenius, Bad Homburg, Germany), nitrocellulose (Protran 0.45 mm, Schleicher and Schuell, Dassel, Germany), Dismembrator S (B. Braun, Melsungen, Germany). Buffer 1 contained 10 mmol/l NaHCO 3 pH = 7.4, 0.25 mol/l sucrose, 5 mmol/l NaN 3 , freshly added protease inhibitor cocktail (Sigma, P8340) and 100 mmol/l PMSF, Bio-Rad-Kit (Biorad, Munich, Germany), NET-G (150 mmol/l NaCl, 5 mmol/l EDTA, 50 mmol/l TRIS-HCl pH 7.5, 0.05 Triton X-100, 0.25 g Gelatin (microbiology grade, Merck, Darmstadt, Germany). Antibodies against IR b, PY99, IRS-1, Ptd(Ins) 3' kinase-p85, PKB, PKC-isoforms, and GLUT1 and GLUT4 were purchased from Santa Cruz Technologies (Autogen Bioclear UK, Calne, Wiltshire, UK), pAkt1 (ser471) was purchased from Upstate Biotechnology (Lake Placid, N. Y., USA).
Animals. All surgical procedures performed in this study were approved by the local Animal Experimentation Ethics Committee and the principles of laboratory animal care (NIH publication no. 85±23, revised 1985) were followed. Female Wistar rats weighing about 300 g were purchased from Charles River, Sulzfeld, Germany and were kept at 22 C with a 12 h lightdarkness cycle and a relative humidity of 55±60 % during the whole experimental period. The rats were given free access to water and standard chow pellet diet (Altromin 1324, Altromin-Futterwerk, Lage, Germany).
Prolonged glucose infusion into conscious rats. Glucose infusion was performed as previously described [41] . Briefly, each rat was anaesthetized with an intraperitoneal injection of a mixture of Ketanest and Rompun at 45 mg/kg and 12 mg/kg, respectively. Then 2±3 drops of atropine sulfate solution (1 mg/ml) was added for each millilitre of this mixture. Surgery was performed at semisterile conditions, using sterile instruments. A 1 cm long incision was made between sternum and mandibula, right external jugular vein was exposed by blunt dissection and was dissected free of the surrounding connective tissue. The jugular vein was cranial ligated and the vein was incised distal to the ligature. Catheters were constructed and were made of silicone rubber, polyethylene tube and silicone catheter fleece. The catheter were filled with 50 IU heparin in 0.9 % saline and introduced into the vein so that its tip lay just before the right atrium. The catheter was then anchored by double ligature. The free end of the catheter was then routed dorsally subcutaneous to the back of the neck. A second incision was then made and the catheter was externalised and fixed using a Teflon anchoring device. The incision was then sutured. Externalised catheter was routed through a flexible spring tether to a swivel and connected by an oscillating arm to a Perfusor syringe pump. The rats were housed singly in a cylindrical Plexiglas metabolic cage and allowed to recover for 48 h after which glucose infusion (2.77 mol/l glucose) was started at a rate of 2 ml/h (GR) versus 77 mmol/l saline in-fusion at 2 ml/h (C). A glucose and a saline-infusion were carried out at a time. Rats were allowed water and chow pellet ad libitum. Blood samples were taken from the tail vein and glucose and insulin concentrations were determined as previously described [41] .
Isolation of hindlimb muscle. After 2 days or 5 days of continuous glucose or saline infusion, experiments were terminated by disconnecting the syringe pump. Rats were then immediately removed from the Plexiglas cage and killed. Hindlimb muscles were quickly excised, dissected free of connective tissue and fat and chopped in small pieces. This step was carried out on ice. Chopped muscles were immediately frozen in liquid nitrogen and subsequently stored at ±80 C until further preparation.
Plasma membrane preparation for the assessment of translocation of PKCs. Aliquots of excised muscles were weighed, ground in a liquid nitrogen-cooled porcelain mortar using a porcelain pistil. Muscles were subsequently placed in liquid nitrogen-cooled Dismembrator S (Braun, Melsungen, Germany) and powdered at setting 2000 rpm for 1 min. Powdered muscles were placed in ice-cold buffer 1. Further homogenisation was carried out with a motor-driven Potter-Elvehjem Teflonglass tissue grinder (Braun, Melsungen, Germany) at setting 1500 rpm and about 10 cycles. Crude muscle homogenate was then spun at 186 000g for 1 h using TLA 55 rotor (Beckman, Munich, Germany) and Optima Max centrifuge (Beckman). The supernatant was referred to as cytosolic fraction, whereas the pellet contained microsomal membrane fraction. The latter was resuspended in buffer 1 containing 1 % Triton X-100, solubilized and centrifuged again at 10 000g in MLA 80 rotor (Beckman) for 10 min. The supernatant was retained and referred to as microsomal membrane fraction. All steps were carried out at 4 C.
Immunoprecipitation of IR and IRS-1. The immunoprecipitation procedure was used for the isolation of the insulin receptor and IRS 1. Briefly, 200 mg of mixed hindlimb muscle were pulverised in a mortar and Dismembrator S and subsequently suspended in 1.5 ml buffer containing 50 mmol/l HEPES pH 7.5, 150 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 1 mmol/l EGTA, 10 % glycerol, 1 % Triton X-100, 100 mmol/l NaF, 10 mmol/l Na 4 P 2 O 7 , and freshly added 1 mmol/l PMSF, 20 ml/1.5 ml buffer protease inhibitor cocktail and 400 mmol/l Na 3 VO 4 . Homogenate was then pottered as described above and spun at 10 000g for 10 min and the pellet was discarded. The last step was repeated. The protein concentration of the supernatant was measured, diluted with buffer to 10 mg protein/ml and 100 ml of the latter dilution were added to 10 ml Protein-ASepharose and 10 ml Sepharose (Pharmacia, Freiburg, Germany) and mixed. IR or IRS-1-antibodies (5 mg) were added and gently rocked overnight at 4 C. Thereafter, beads were spun down at 500 rpm for 1 min. The pellet was washed three times and resuspended in 20 ml washing buffer (50 mmol/l HEPES pH 7.5, 150 mmol/l NaCl, 0.1 % Triton X-100, 10 % glycerol, 100 mmol/l NaF and freshly added 2 mmol/l Na 3 VO 4 ). Eventually, Laemmli buffer was added and cups were heated at 98 C for 10 min. Supernatants were then quantitatively transferred to 7.5 % SDS-PAGE (100 mg protein), separated and detected as described below. Tyrosine phosphorylation was determined using the non site-specific anti-phosphotyrosine-antibody PY99.
Determination of IRS-1-associated Ptd(Ins) 3' kinase activity. IRS-1-associated Ptd(Ins) 3' kinase was determined after immunoprecipitation with IRS-1 antibody conjugated to beads [18] . Briefly, collected immunoprecipitate were washed with phosphate-buffered saline pH 7.5 containing 1 % NP-40 and 100 mmol/l Na 3 VO 4 . Additional wash steps were performed and the enzyme activity was measured by incubation with Phosphatidylinositol (Avanti, Albaster, USA) and g 32 P[ATP]. Lipids were extracted using CHCl 3 :CH 3 OH [1:1] and radiolabelled product was separated by thin layer chromatography and detected by autoradiography.
Subcellular fractionation of rat skeletal muscle. Subcellular fractionation was carried out [42] with minor modifications. Mixed hindlimb muscles (5 g) were ground and homogenized as described above. The powdered muscle was placed in buffer 1 (5 g / 75 ml buffer 1) and pottered as described above. Subcellular fractionation was done for two experimental conditions at a time, ie. skeletal muscle of a control rat (C) and of a glucose-infused rat (GR). Muscle homogenate was spun at 1300g for 10 min to remove large aggregates, nuclei and connective tissue. The postnuclear supernatant was saved and low spin pellet was resuspended, homogenized and pelleted again at 1300g for 10 min (low spin pellet). Postnuclear supernatants were pooled and centrifuged at 9000g for 10 min. Supernatant was centrifuged at 190 000g for 1 h to yield the membrane-enriched pellet (microsomal pellet). Microsomal pellet was again resuspended, topped on a sucrose step gradient [42] and centrifuged at 150 000g for 7 h in swing-out rotor. Interphases from the gradient were then collected, diluted with sucrose free buffer 1 and repelleted at 444 000g for 1 h. The low spin pellet is enriched in unbroken, partially broken cells as well as large sheets of the plasma membrane and T-tubules regions and contains about 40 % of total GLUT4 and more than 50 % of sarcoplasmatic reticulum [7] . Repeated washing of this pellet recovers no more than 20±30 % of the surface membranes [7] . Therefore, low-spin pellet was resuspended in LiBrcontaining buffer (50 mmol/l TRIS-HCl, 0.5 mol/l LiBr) and stirred at 4 C for 4 h. LiBr was added to break actin-myosin bond and liberates GLUT4-enriched internal membranes as previously described [42] , [43] . The resulting homogenate was then first spun at 1200g for 5 min, the supernatant was centrifuged at 10 000g for 10 min. The supernatant was centrifuged at 53 000g for 18 min to pellet a plasma membrane fraction enriched in T-tubules. The supernatant was centrifuged at 416 000g for 1 h to pellet intracellular membranes enriched in GLUT4. Pellets were resuspended in appropriate volume of buffer and protein concentration was measured.
Purity assessment of separated fractions. Identification and purity assessment of the separated fractions was previously described [42] . For characterization of the plasma membrane-enriched fractions we used a1 subunit of Na + -K + -ATPase as described [44, 45] . For the characterization of fractions of enriched in transversal tubules the dihydropyridine receptor a1 subunit (a1 DHPR) was used [45, 46] .
Detection of GLUT4 and PKC isoforms by SDS-PAGE and immunoblotting. Protein concentrations were determined using the dye-based Bradford assay (Bio-Rad-Kit). Aliquots of proteins were applied to 7.5 % SDS-PAGE [47] . Proteins were transferred to nitrocellulose by electroblotting. Nitrocellulose membranes were subsequently soaked with blocking agent (NET-G) for 1 h at room temperature. The first antibody dissolved in NET-G was then added and gently agitated for 2 h at room temperature or overnight at 4 C. Membranes were subsequently washed in NET-G twice for 15 min each time and the horseradish peroxidase-conjugated second antibody was added and incubated at room temperature for 1 h. Antibody detection was performed using a chemiluminescent de-tection reagent (Amersham-Pharmacia, Freiburg, Germany). Emitted light was collected on Hyperfilm ECL (Amersham, Freiburg, Germany). Films were developed using a Sterling Diagnostic Imaging apparatus (Du Pont de Nemours, Bad Homburg, Germany) and analysed by scanning densitometry using Sharp Scanner JX-330.
Measurement of glycogen and triglycerides in rat skeletal muscle. Glycogen assay from rat skeletal muscle was performed as previously described [48] . Briefly, 0.75 ml of preheated (40 C) citrate buffer (100 mmol/l sodium citrate, pH 5.0) were added to 100 mg of pulverised mixed hindlimb muscle, mixed well and homogenized using Potter S at 1500 rpm for 30 s. Two sets of aliquots of 200 ml were made from each sample. One of the sets was incubated with 0.5 % amyloglucosidase in citrate buffer at 55 C for 150 min with periodical agitation (amyloglucosidase from aspergillus niger, A7420, Sigma, Munich, Germany). Samples were then centrifuged at 28 000 rpm in TLA 55 rotor (Beckman, Munich, Germany) for 30 min. Supernatants were measured using YSI analyzer (YSI 2300 STAT Plus, Kraienbaum, Langenfeld, Germany). Observed and expected glucose readings of 0.1 % glycogen standard (Type III from rat liver, Sigma) were processed for quantification. Triglycerides were analysed as described recently [40] .
Preparation of total RNA from rat skeletal muscle and RT-PCR. To isolate RNA, we used an optimized one step guanidinium isothiocyanate/phenol method (peqGOLD TriFast, peqLab Biotechnology, Erlangen, Germany). Isolation was done according to manufacturer's instructions. Reverse transcription was performed using a first strand cDNA synthesis Kit for RT-PCR with AMV (avian myeloblastis virus) as reverse transcriptase (Roche Diagnostics, Mannheim, Germany) and random primer p(dN) 6 . Reverse transcription was done in Perkin-Elmer-PCR-System 9700 (Überlingen, Baden-Württem-berg, Germany). Primer design was made from a gene sequence of a discrete DNA segment, which was obtained from the Genome-GenBank. PCR was accomplished using the Light-Cycler-System (Roche Diagnostics, Mannheim, Germany). The SYBR Green I dye (Roche Diagnostics, Mannheim, Germany) was used for DNA detection. Beta globin was used as external standard for quantification, known amounts of beta globin were simultaneously run with samples and quantification was performed using the Light-Cycler-software version 3.0. Control rats were set at 100 % and comparison was made to the corresponding treated rats. PCR product sizes were verified by gel electrophoresis on 2 % agarose. Primers used are listed in Table 1 .
Statistical analysis. All data are expressed as means SEM. Data were analysed using the unpaired Student's t test for the comparison of mean values. Data are expressed in per cent of control animals. A p value of less than 0.05 was considered to be statistically significant.
Results
Metabolic effects of continuous glucose infusion. Continuous glucose infusion into rats for 7 days induced transient hyperglycaemia and persistent hyperinsulinaemia (Table 2) . Hyperglycaemia peaked after 24 h of glucose infusion. Despite further continuous glucose infusion, plasma glucose reached normal values in infused rats compared to controls in the fifth day (day 5: 7.3 0.4 GR vs 6.9 0.06 mmol/l C) and remained normal after day 7. We observed about a 20-fold increase in serum insulin concentration after one day of glucose infusion which declined thereafter but remained elevated throughout the glucose infusion period (5d: 219 10 GR vs 38 1 mU/ml C). Saline infusion affected neither plasma glucose nor insulin concentration in control rats (Table 2) . Glucosuria was present after 2 days but was absent after 5 days (Table 3) . As expected, glucose-infused rats showed faster weight gain and lower food consumption ( Table 3 ). The parallel reduction of both glucose and insulin concentrations indicates the action of an insulin-independent glucose uptake system. Because the metabolism of the rats changed from the hyperglycaemic/hyperinsulinaemic state in day 2 to the normoglycaemic/hyperinsulinaemic state in day 5, we focused our studies on these two time points. To assess whether increased glucose uptake into skeletal muscle and subsequent enhanced glucose utilization had occurred, glycogen and triglycerides content were measured. As shown in Table 3 glycogen content increased more than 10-fold after 2 days of glucose infusion and was less increased after 5 days (3.5-fold). The muscle triglyceride content was increased (p < 0.05) after 2 days and remained higher after 5 days of glucose infusion. These data, together with the weight gain (p < 0.05) clearly indicate that the excess glucose was utilized.
Insulin signalling cascade.
Earlier studies with this model have shown that continuous glucose infusion induces both increased glucose metabolism and insulin resistance in rat skeletal muscle [39, 40, 49] . To see if increased glucose-uptake in glucose-infused rats is mediated by an enhanced insulin action, we studied the amount and activity of the known early steps insulin signalling proteins. Extracts from rat skeletal muscle were analysed by Western blotting. A typical experiment is shown in Figure 1 and all data measured are summarized in Table 4 . We found that protein and mRNA expression and phosphorylation of proteins of the insulin signalling cascade were not increased after 2 days and particularly after 5 days of glucose infusions compared to control rats who had free access to food. Although we observed an increased tyrosine-phosphorylation of the IR and IRS-1 in any individual glucose-infused rat in the day 2 (data not shown), this finding was not statistically significant when all animals were assessed (Table 4). Of note, we did not find any enhanced phosphorylation of the IR and IRS-1 in individual glucose-infused rats compared to control rats in day 5 suggesting that long-term glucose oversupply leads to failure of the stimulation of the early steps of the insulin signalling cascade in spite of grossly elevated insulin concentrations. These data show that the previously found insulin resistance in this animal model could be traced down to the molecular level. The quantification of the Western blots show that insulin receptor expression and tyrosine phosphorylation were reduced (p < 0.05) in day 5 to the same extent, Table 4 . Effect of glucose infusion on the insulin signalling cascade in rat skeletal muscle. IRS-1-associated Ptd(Ins) 3' kinase activity was determined after immunoprecipitation with IRS-1 antibody conjugated to beads. Western blots, as shown in (Fig. 1) , from three independent experiments were scanned. Quantification of mRNA was measured using the Light Cycler system in three independent experiments. Values are expressed as percent of controls, which were set at 100 %. indicating no increase in insulin receptor activation in glucose-infused rats (Table 4) . Furthermore, the expression of the downstream signalling proteins IRS-1, Ptd(Ins) 3' kinase-p85, PKB and the tyrosine phosphorylation of IRS-1 as well as serine-473 phosphorylation of PKB were not affected. Because activation of Ptd(Ins) 3' kinase has been shown to be an essential step in insulin-dependent stimulation of glucose transport, IRS-1 associated Ptd(Ins) 3' kinase from muscle extracts was precipitated using IRS-1 antibody and analysed for enzymatic activity using thin layer chromatography for the separation of the radioactive Ptd(Ins) 3' kinase product as previously described [18] . No significant increase in IRS-1-associated Ptd(Ins) 3' kinase activity was found in glucoseinfused rats (Table 4) . Similarly, expressions of the mRNA of the investigated proteins, except IR, were not significantly changed (Table 4 ). It appears that after 5 days of glucose infusion a down regulation of the IR is initiated. Together, these data indicate that neither expression of the components of the insulin signalling cascade nor their activity is significantly increased by continuous glucose infusion after 2 or 5 days. These data explain the earlier finding that glucose oversupply induces insulin resistance in skeletal muscle [39, 40, 49] .
Expression of GLUT1 and GLUT4 protein. Because prolonged glucose infusion stimulated glucose utilization in skeletal muscle, as assessed by an increase in glycogen and triglyceride content, without employing the insulin signalling cascade, we examined any insulin-independent effects on the glucose transporters GLUT1 and 4. First, we studied if continuous glucose infusion had altered the expression of GLUT1 and GLUT4. Skeletal muscle homogenates were prepared from GR and controls, and equal amounts of protein (100mg) were loaded on the gel. Western blotting revealed an increase in protein expression of GLUT4 after 2 days of glucose infusion (p < 0.01) which remained slightly increased after 5 days of glucose infusion (p < 0.05) (day 2: 158 4** % of control; day 5: 111 3*% of control) (Fig. 2) . In contrast, no changes in GLUT1 protein expression were found (data not shown).
The translocation of GLUT1 and GLUT4. Previous studies have shown that an appreciable amount of GLUT1 and GLUT4 protein is located in intracellular vesicles. However, only the glucose transporters which are inserted into the plasma membrane are functionally active [9] . Therefore, we determined the presence of the glucose transporter proteins GLUT1 and GLUT4 in the plasma membrane of rat skeletal muscle to assess whether in vivo glucose infusion induced the translocation of the transporters. Because insulin induces the translocation of GLUT4 particularly to the transversal tubules (TT) of the plasma membrane [42, 50, 51] this membrane compartment was also studied. The identity and purity of the TT fraction was assessed by the presence of a 1 dihydropyridine receptor which is exclusively located in the TT membranes [52] . We observed an increase of GLUT4 in all plasma membrane fractions studied after 2 days while the effect was much less pronounced after 5 days of glucose infusion (Fig. 3A) . Characterization of the plasma membrane fractions by blotting against the a 1 -subunit of the Na + -K + -ATPase, a marker for plasma membranes, showed that this Fig. 1 . Effect of glucose infusion on the insulin signalling cascade in rat skeletal muscle after day 2 and day 5 of glucose infusion. Glucose infusion (5.6 mmol/h) (GR) and continuous infusion of 154 mmol/h NaCl into control rats (C) was done as described in the Methods. Representative Western Blots from three independent experiments are shown Fig. 2 . Protein expression of GLUT4 in rat skeletal muscle after 2 and 5 days of glucose infusion. Homogenates were prepared from glucose-infused (GR) and control (C) rats and Western blotting was performed. Representative Western blots are shown from a set of three independent experiments marker was clearly enriched in the 32 % and 35 % sucrose gradient and in the gradient pellet (Fig. 3A) , indicating that these fractions originate from the plasma membrane. The 25 % fraction mainly containing intracellular membranes also showed a small increase in GLUT4 after glucose infusion. This increase could be caused by the contamination with plasma membrane fraction because this fraction contains small but noticeable amounts of the a 1 -subunit of the Na + -K + -ATPase (Fig. 3A) . Furthermore, we investigated whether increased translocation affected the intracellular pools. GLUT4 was almost completely depleted in the intracellular membranes after 2 days and to a lesser extent after 5 days of glucose infusion (Fig. 3B) . Although the absolute content of the GLUT4 protein varied, a clearly increased GLUT4 translocation was observed in three different membrane preparations. These data indicate that in the presence of insulin hyperglycaemia caused a persisting induction of glucose uptake through GLUT4 translocation. No change in GLUT4 content was observed in the transversal tubule membrane fraction after 2 days or 5 days of glucose infusion (Fig. 3B) .
To evaluate the specificity of this effect, we also studied GLUT1 in the different cell compartments using the same fractions as described above. In contrast to GLUT4, GLUT1 is primarily located in intracellular membranes (25 % fractions) and to a lesser extent in the plasma membranes of the 32 % and 35 % fraction. No change of GLUT1 content was observed in any of the membrane fractions after day 2 or after day 5 of glucose infusion (data not shown), indicating that the persisting hyperglycaemia-induced glucose uptake is not mediated by GLUT1.
The translocation of PKC isoforms. As outlined by several earlier studies high glucose could activate PKC. Activated PKC isoforms inhibit insulin signalling and stimulate GLUT4 translocation. Therefore, the cellular localization of the PKC isoforms PKC-a, -bI, -bII, -q, -l, -d and -z was studied to assess possible activation by the experimental metabolic conditions. Because PKC-e is known to be translocated in skeletal muscle in this animal model [40] , this isoform was not investigated here. Equal amounts of proteins A B Fig. 3 (A, B) . Effect of glucose infusion on the distribution of GLUT4 in cellular compartments of rat skeletal muscle after day 2 and day 5. Plasma membrane fractions obtained by step gradient centrifugation are shown in (A). Intracellular fractions and transverse tubule (TT) membranes are shown in (B). a1-Subunits of Na + /K + -ATPase and dihydropyridine receptor (a1 DHPR) were determined to assess the purity of the obtained fractions. Representative Western Blots of three independent experiments are shown from the plasma membrane and the cytosol fractions were separated by gel electrophoresis and were immunoblotted. The specificity of the antisera was verified by competition with the peptide used for immunisation (data not shown). The cPKCs -a, -bI and -bII (g is not expressed in skeletal muscle) were enriched in the PM after 2 days of glucose infusion and the corresponding cytosolic fractions were simultaneously depleted (Fig. 4) . Quantification of the data (Table 5) indicated that the glucose infusion caused more than 3-fold enrichment of PKC-bI and -bII in the PM, ie. the highest increase of all PKC isoforms studied, while the effect on PKC-a was much smaller. The cytosolic fraction was substantially reduced in PKC-a, -bI and -bII after 2 days (Table 5 ). After 5 days the changes were no longer detectable. Specific bands of the novel PKC -d and -q were immunodetectable. PKC-q increased (p < 0.05) in the PM after 2 days but not after 5 days of glucose infusion (Table 5). The slight increase of PKC-d on day 2 was not statistically significant. We found no increased translocation of PKC-z in skeletal muscle samples after 2 days or 5 days. When we used PKC-l antibody, we obtained no specific immunoreactivity. To exclude a possible effect of glucose infusion on PKC expression, we investigated the amount of total PKC isoforms present in homogenates by Western blotting and PKC isoform mRNA by real time RT-PCR. No specific change in the protein or mRNA expression of any of the isoforms studied was found in day 2 or day 5 ( Table 6 ). The results show that continuous glucose infusion leads to translocation of PKC-a, -q and particularly -bI and -bII and that the translocation was only evident when hyperglycaemia was present.
Discussion
Studies in diabetic and normal subjects have indicated that hyperglycaemia induces an increase in glucose uptake which has been attributed to mass action of glucose [16] . Our previous in vitro studies with cultured myotubes and isolated skeletal muscle show that short-term hyperglycaemia induced an insulinindependent glucose uptake and a parallel translocation of GLUT4 to the cell surface, indicating that high glucose concentrations could activate their own uptake system [17] . However, numerous hormones, such as glucagon, catecholamines, thyroid hormone and other still ill-defined mediators, mediating the cross-talk between fat and muscle, influence glucose uptake and metabolism rendering the in vivo situation much more complex. To address the molecular mechanisms of hyperglycaemia-induced glucose up- Fig. 4 . Effect of glucose infusion on the translocation of PKC isoforms in rat skeletal muscle. Hindlimb skeletal muscles were prepared from glucose-infused (GR) or saline-infused (C) rats and the plasma membrane and cytosolic fraction was obtained as described in Methods. Representative Western blots are shown from a set of three independent experiments take in vivo, we used the glucose-infused rat model originally developed by Leahy et al. [38] . In this model, rats adapt to and minimize the degree of hyperglycaemia despite continuously ongoing systemic glucose oversupply [39, 53] . This adaptation cannot be explained by compensatory renal glucose clearance [39, 53] . As previously shown, not all glucose is taken up by muscle and fat tissue but also by the liver and other tissues indicating a role of these organs in glucose homeostasis [53] . Because insulin resistance rapidly develops in the skeletal muscle of the glucose-infused rats [39, 53] it seems that glucose in itself could play a major role in the adaptation process, ie. accommodation of systemic glucose oversupply and return to normoglycaemia.
Using this animal model, we confirmed previous reports of rapid adaptation of the rats to the glucose infusion resulting in normoglycaemia and persistent hyperinsulinaemia after 5 days. Reduced food intake cannot account for the normalization of the plasma glucose values because the amount of infused glucose (24 g/d) clearly exceeds the amount of reduced food uptake (5 g of chew pellet) by far. Investigating the underlying molecular mechanism, we found that the normalization of blood glucose concentration was mediated at least partially by an increased translocation of GLUT4 to the plasma membrane of skeletal muscle because an increase in GLUT4 protein in all plasma membrane fractions studied was detected. GLUT1 appeared not to be involved in the increased glucose uptake because no changes in either translocation or protein expression were detected. Because insulin induces the translocation of GLUT4 in skeletal muscle, we studied whether the insulin signalling cascade was more activated in GR than in ad libitum fed control animals. Activation of insulin signalling could be assessed by determination of the tyrosine phosphorylation of the insulin receptor and the well characterized proximal substrate molecule IRS-1 [54] . Phosphorylation of IRS-1 creates binding sites for the regulatory p85 subunit of Ptd(Ins) 3' kinase, a key mediator in insulin signalling. IRS-associated Ptd(Ins) 3' kinase produces phosphatidylinositol-3,4,5-phosphate which activates phosphatidylinositol-3,4,5-phosphate-dependent-kinase-1, in turn activating PKB by phosphorylation at ser 473 [55] . Because activated PKB is thought to transmit the insulin signal to glucose uptake and to glycogen synthesis, activation of PKB was also studied in GR [55] . Recently, insulin-dependent activation of PKC-z has been implicated in insulin signalling [32] . Although many components of the signalling pathway of insulin-induced translocation of GLUT4 have been characterized, the complete sequence of events is not known [55] . Because the expression of the insulin receptor [56] and other insulin signalling proteins could vary, we estimated both the mRNA and the protein expression of the signalling proteins [54] .
The insulin signalling cascade particularly in day 5, as assessed by the determination of phosphorylation of the insulin receptor, IRS-1 and PKB, was not further activated when compared to control rats suggesting that the increased GLUT4 translocation is not mediated by the insulin-dependent steps studied. In addition, the PKC isoform z previously shown to be activated by insulin was not changed providing further support for the inhibition of the early steps of insulin signalling cascade [32] . Noteworthy, in contrast to an insulin-dependent GLUT4 translocation [12, 13, 14] , we observed no translocation of GLUT4 to Table 5 . Quantification of the effect of glucose infusion on PKC isoforms translocation. Western blots as shown in (Fig. 4) Data represents means SEM *p < 0.05 Table 6 . Effect of glucose infusion on PKC isoforms mRNA expression. mRNA expression of PKC isoforms were determined by RT-PCR. Results from three independent experiments were used. Values are expressed as % of controls, which were set at 100 %. the transverse tubules in GR providing more evidence for a possibly different mechanism of insulininduced and hyperglycaemia-induced GLUT4 activation. We previously reported that high glucose concentrations interact in a dual way with the insulin signalling cascade; hyperglycaemia induced translocation of GLUT4 in three different muscle-derived model systems [17] and hyperglycaemia induced insulin resistance in rat-1 fibroblasts [19] . In agreement with this, several studies reported an hyperglycaemia-induced increased glucose uptake [18, 20] . In this study, we found such an effect on GLUT4 translocation in whole, insulin-resistant animals. It is probable that the increase in GLUT4 expression and translocation is responsible for lowering of blood glucose because the increased glycogen and lipid content in the skeletal muscle of GR provides evidence for the functionality of the translocated GLUT4.
Because the increased GLUT4 translocation does not seem to be mediated by an enhanced activation of the early steps of insulin signalling, we studied the possible mechanism of this effect. Several studies suggested a role of PKC in hyperglycaemia-induced glucose uptake [17, 18, 20] and in insulin resistant states [19, 25, 57±59] . PKC overexpression or long-term exposure to TPA down regulates IRS-1 expression and leads to insulin resistance [60] . We have previously reported that the PKC isoform b is important for the short-term high glucose effect in muscle [17] . Hyperglycaemia has been shown to induce translocation of PKC-bI and -bII [20] . However, the effect on PKCbI failed to reach statistical significance in the latter study. PKC isoform b was reported to be activated under hyperglycaemic conditions in breast cancer cells [61] , in C 2 C 12 myotubes and rat skeletal muscle [17, 18] , in rat heart muscle [30] and in human skeletal muscle cells [62] . Overexpression of PKC-bI and PKC-bII but not PKC-d, -e, -q or -z inhibited the tyrosine kinase activity of the insulin-stimulated insulin receptor [57] . Our finding of an hyperglycaemia-induced PKC-bI/bII translocation in skeletal muscle of glucose-infused rats is well in line with these studies. Recently, the effect of PKC activation on insulin signalling in ex vivo rat soleus muscle was studied [63] . Muscle preincubated for 1 h with 1mmol/l phorbol ester resulted in translocation of PKC -a, -bI, ±bII, -e and -q similar to our present results obtained in intact glucose-infused rats. The phorbol ester treated muscles showed an impaired ability of insulin to stimulate glucose incorporation into glycogen while insulinstimulated glucose transport and oxidation and glucose incorporation into lipid was not affected. Of note, we found a relative decrease in glycogen content after 5 days while the lipid content was not changed (Table 3 ). The pharmacological PKC activation decreased insulin-stimulated phosphorylation of the insulin receptor, PKB and glycogen synthase kinase 3 while Ptd(Ins) 3' kinase activity was less reduced. These results indicate that phorbol-ester-stimulated activation of PKC leads to an impairment of several but not all events in the insulin signalling cascade. The striking similarity of these results to our data indicate that the observed PKC activation could actually cause the effects in our in vivo model of glucose oversupply.
Using the same animal model, investigators [40] showed that PKC-e, but not PKC-a, -d or -q was translocated in the day 1 and day 4 of continuous glucose infusion; PKC-b was not studied. These and our data indicate that the PKC isoforms a, b and possibly q (this study) and e [40] could be most relevant to explaining the effects observed in this animal model. Including the results obtained by in vitro studies, it could well be that these PKC isoforms activated by hyperglycaemia regulate signalling in a dual way: inhibition of early steps of insulin signalling as well as opening of an hitherto unknown signalling pathway which induces GLUT4 translocation. Because high insulin concentrations are present at both time points studied, we cannot rule out an insulin-mediated increase in GLUT4 translocation. An IRS-1-and PKB-independent pathway for insulin-dependent GLUT4 translocation has been characterized [64] . Furthermore, other proteins of the IRS family could be involved because eg. IRS-2 deficient mice also have abnormalities in peripheral insulin action [65] . In addition, there could be other unknown insulin-dependent or insulin-independent signalling cascades which induce the increase in glucose uptake. Although plasma insulin concentrations remain high after the 5 days of glucose infusion, they are not believed to be high enough to activate IGF-1 receptormediated glucose uptake.
A study of the molecular mechanism of PKC activation and induction of insulin resistance in this animal model found an increased accumulation of longchain acyl-CoA which could be linked to an activation of PKC and insulin resistance [40] . Furthermore, they found an increased triglyceride content in skeletal muscle similar to our results [49] . Noteworthy, higher muscle triglycerides concentrations have been detected in insulin-resistant non-diabetic human subjects [66, 67] . Studies provide evidence that the hexosamine biosynthetic pathway is involved in the development of insulin resistance [68] . Hyperglycaemia increases GFAT activity and GFAT activity is increased in hyperglycaemic obese mice and in hyperglycaemic subjects with Type II diabetes [69±71]. Transient overexpression of GFAT leads to insulin resistance indicating that this pathway could also be activated in skeletal muscle of glucose infused rats [72] . Of note, recent results showed that activation of this pathway leads to activation of PKC [21] and induces translocation of the PKC isoforms a, e and particularly b, but not z [73] supporting the possibility of an involvement of the hexosamine pathway in the pathogenesis of insulin resistance.
In summary, this study suggests that in skeletal muscle of long-term glucose-infused rats early steps of insulin signalling are impaired possibly leading to reduced glycogen synthesis while triglyceride accumulation is not affected. Our data indicate that glucose is taken up by activation of GLUT4 possibly mediated by hyperglycaemia-induced activation of PKC.
